Global Robotic-Assisted Bronchoscopy Systems Market Strategic Research Report

Scope of the Report

The global Robotic-Assisted Bronchoscopy Systems market size is predicted to grow from US$ 377 million in 2025 to US$ 947 million in 2032; it is expected to grow at a CAGR of 14.0% from 2026 to 2032.

In 2025, global sales of robotic-assisted bronchoscopy systems are estimated at approximately 350 units, with an average capital system price of about USD 0.8–1.5 million per unit. Robotic-assisted bronchoscopy systems refer to medical robotic platforms designed to access the bronchial tree and peripheral lung regions through the natural airway. Under physician control, these systems integrate robotic motion control, route planning, navigation, imaging support, and flexible instrument delivery to enable visualization, localization, targeted access, biopsy sampling, and related bronchoscopic interventions for peripheral pulmonary nodules, suspected lung cancer lesions, and other lung abnormalities. A typical system consists of a robotic control platform, physician controller, navigation and planning workstation, flexible bronchoscope or robotic catheter, guiding sheath, dedicated biopsy instruments, and integrated software modules, and is mainly used in interventional pulmonology, early lung nodule diagnosis, lung cancer diagnosis, and pulmonary lesion localization.

Robotic-assisted bronchoscopy systems are moving from clinical validation toward early-stage commercial adoption. With the wider use of low-dose CT screening, the detection rate of peripheral pulmonary nodules continues to rise, creating stronger demand for more precise and stable transbronchial diagnostic tools. Conventional bronchoscopy still faces limitations in reaching peripheral lesions, maintaining tool stability, and improving diagnostic yield. By integrating robotic control, route planning, navigation, imaging support, and flexible instrument delivery, robotic-assisted bronchoscopy systems are becoming an important technology platform for early lung nodule diagnosis and the upgrading of interventional pulmonology.

From a market perspective, this segment remains an early-growth area within high-end medical equipment. The global market size is estimated at approximately USD 860 million in 2025 and is expected to reach around USD 990 million in 2026, with a projected CAGR of about 14.3% from 2026 to 2032. Near-term growth will mainly be driven by higher utilization of installed systems in the United States, increasing consumption of dedicated scopes and procedure-specific accessories, and the early commercial rollout of China-based platforms. Over the medium to long term, market expansion will depend on broader lung nodule screening, hospital investment in interventional pulmonology capabilities, declining robotic platform costs, and the gradual expansion of therapeutic bronchoscopic applications.

The competitive landscape is currently concentrated among a limited number of system-level OEMs. U.S. companies lead in product maturity, installed base, and physician training, while Chinese players are accelerating commercialization after regulatory approvals and clinical progress. Intuitive Surgical, Johnson & Johnson MedTech, and Noah Medical represent the major global players, while Edge Medical, MicroPort MedBot, and LungHealth MedTech are the key China-based participants. Future competition will extend beyond capital systems to navigation accuracy, tool-in-lesion confirmation, disposable instrument economics, consumable recurrence, workflow integration, and real-world clinical evidence. Overall, the market has strong clinical demand and long-term growth potential, but near-term adoption will remain influenced by capital equipment pricing, hospital budgets, physician learning curves, reimbursement conditions, and the pace of clinical evidence generation.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Robotic-Assisted Bronchoscopy Systems market?

What factors are driving Robotic-Assisted Bronchoscopy Systems market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Robotic-Assisted Bronchoscopy Systems market opportunities vary by end market size?

How does Robotic-Assisted Bronchoscopy Systems break out by Type, by Application?

This report presents a comprehensive overview of the global Robotic-Assisted Bronchoscopy Systems market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Robotic Bronchoscopy Capital Systems
• Dedicated Robotic Bronchoscopy Instruments
• Other

Segment by Application

• Peripheral Pulmonary Nodule Biopsy
• Lung Lesion Localization and Marking
• Other

Segment by Application

• Hospitals
• Specialty Clinics and Diagnostic Centers
• Other Healthcare Facilities

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Robotic-Assisted Bronchoscopy Systems market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospitals, Specialty Clinics and Diagnostic Centers, Other Healthcare Facilities evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact